Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer
- PMID: 20145612
- PMCID: PMC2833255
- DOI: 10.1038/sj.bjc.6605564
Factors that contribute to faecal cyclooxygenase-2 mRNA expression in subjects with colorectal cancer
Abstract
Background: We previously reported that a faecal cyclooxygenase-2 (COX-2) mRNA assay was useful for identifying colorectal cancer (CRC). This study sought to investigate the factors that contribute to faecal COX-2 mRNA expression in subjects with CRC.
Methods: The study cohort comprised 78 patients with CRC and 36 control subjects. The expressions of COX-2, beta-2-microglobulin (B2M), carcinoembryonic antigen (CEA), E-cadherin (E-cad), and CD45 mRNA in faeces and COX-2 mRNA expression in tissue were determined by quantitative real-time RT-PCR.
Results: The level of faecal expression of COX-2 mRNA in CRC was significantly higher than that in controls. A significant correlation was found between faecal COX-2 mRNA expression and faecal B2M, CEA, E-cad, or CD45 mRNAs, markers of exfoliated total cells, colonocytes, and leukocytes, respectively. A significant correlation was found between the expression of COX-2 mRNA in faeces and tumour surface area, COX-2 mRNA expression in primary tumour. There was no difference in faecal COX-2 mRNA expression between proximal CRC and distal CRC.
Conclusion: COX-2 mRNA expression in faeces seems to originate from tumour lesion and to be affected by factors such as the number of exfoliated cells, exfoliation of inflammatory cells, COX-2 mRNA expression in tumour, and tumour size.
Figures

Similar articles
-
Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.Cancer Epidemiol Biomarkers Prev. 2009 Jun;18(6):1888-93. doi: 10.1158/1055-9965.EPI-08-0937. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19505922
-
Potential usefulness of detecting cyclooxygenase 2 messenger RNA in feces for colorectal cancer screening.Gastroenterology. 2004 Aug;127(2):422-7. doi: 10.1053/j.gastro.2004.05.022. Gastroenterology. 2004. PMID: 15300574 Clinical Trial.
-
Faecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer.J Cell Mol Med. 2008 Oct;12(5B):1936-43. doi: 10.1111/j.1582-4934.2008.00253.x. Epub 2008 Feb 4. J Cell Mol Med. 2008. PMID: 18266979 Free PMC article.
-
Over-Expression of Cyclooxygenase-2 in Colorectal Cancer Patients.Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1675-1681. doi: 10.31557/APJCP.2019.20.6.1675. Asian Pac J Cancer Prev. 2019. PMID: 31244287 Free PMC article.
-
Expression of CIAPIN1 in human colorectal cancer and its correlation with prognosis.BMC Cancer. 2010 Sep 3;10:477. doi: 10.1186/1471-2407-10-477. BMC Cancer. 2010. PMID: 20815902 Free PMC article.
Cited by
-
Droplet digital PCR for quantification of ITGA6 in a stool mRNA assay for the detection of colorectal cancers.World J Gastroenterol. 2017 Apr 28;23(16):2891-2898. doi: 10.3748/wjg.v23.i16.2891. World J Gastroenterol. 2017. PMID: 28522907 Free PMC article.
-
MicroRNAs: relevant tools for a colorectal surgeon?World J Surg. 2012 Aug;36(8):1881-92. doi: 10.1007/s00268-012-1603-3. World J Surg. 2012. PMID: 22526047 Review.
-
Over-expression of COX-2 mRNA in colorectal cancer.BMC Gastroenterol. 2014 Jan 2;14:1. doi: 10.1186/1471-230X-14-1. BMC Gastroenterol. 2014. PMID: 24383454 Free PMC article.
-
The expression and significance of feces cyclooxygensae-2 mRNA in colorectal cancer and colorectal adenomas.Saudi J Gastroenterol. 2017 Jan-Feb;23(1):28-33. doi: 10.4103/1319-3767.199112. Saudi J Gastroenterol. 2017. PMID: 28139497 Free PMC article.
-
Decoding immune-related gene-signatures in colorectal neoplasia.Front Immunol. 2024 Jun 24;15:1407995. doi: 10.3389/fimmu.2024.1407995. eCollection 2024. Front Immunol. 2024. PMID: 38979413 Free PMC article.
References
-
- Ahlquist DA, Harrington JJ, Burgart LJ, Roche PC (2000) Morphometric analysis of the ‘mucocellular layer’ overlying colorectal cancer and normal mucosa: relevance to exfoliation and stool screening. Hum Pathol 31: 51–57 - PubMed
-
- Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL (2008) Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med 149: 441–450 - PMC - PubMed
-
- Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539–545 - PubMed
-
- Benchimol S, Fuks A, Jothy S, Beauchemin N, Shirota K, Stanners CP (1989) Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 57: 327–334 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous